Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.25 - $4.05 $97,274 - $175,093
-43,233 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$4.08 - $7.83 $176,390 - $338,514
43,233 New
43,233 $176,000
Q2 2021

Aug 16, 2021

SELL
$6.78 - $9.04 $106,995 - $142,660
-15,781 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.18 - $23.98 $129,088 - $378,428
15,781 New
15,781 $133,000

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.